Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPRODUSTAT for Nephrogenic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 859 adverse event reports in the FDA FAERS database where DAPRODUSTAT was used for Nephrogenic anaemia.

Most Reported Side Effects for DAPRODUSTAT

Side Effect Reports % Deaths Hosp.
Hospitalisation 219 16.3% 8 219
Product use issue 116 8.6% 21 59
Off label use 105 7.8% 25 54
Death 91 6.8% 91 13
Haemoglobin decreased 65 4.8% 11 40
Cardiac failure 61 4.5% 27 32
Dysphagia 58 4.3% 12 41
Renal impairment 56 4.2% 7 26
Haemoglobin increased 53 3.9% 8 32
Marasmus 52 3.9% 47 11
Nephrogenic anaemia 40 3.0% 3 12
Cerebral infarction 39 2.9% 13 31
Condition aggravated 39 2.9% 15 19
Fall 39 2.9% 12 31
Pneumonia 33 2.5% 12 22

Other Indications for DAPRODUSTAT

Product used for unknown indication (39) Chronic kidney disease (14) Anaemia (6)

Other Drugs Used for Nephrogenic anaemia

DARBEPOETIN ALFA (5,332) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331) ARANESP (1,740) ERYTHROPOIETIN (750) PEGZEREPOETIN ALFA (325) EPOETIN ALFA-EPBX (169) VADADUSTAT (140) MIRCERA (100) ENARODUSTAT (66) ROXADUSTAT (57)

Related Pages

DAPRODUSTAT Full Profile All Nephrogenic anaemia Drugs DAPRODUSTAT Demographics DAPRODUSTAT Timeline